Business
Ventyx Biosciences Stock Takes Major Hit on Phase 2 Results
San Diego-based clinical-stage biopharmaceutical firm, Ventyx Biosciences, unveiled pivotal findings from the Phase 2 clinical trial of VTX958, targeted at patients grappling with moderate to...
Stock of Matinas BioPharma Soars on Promising Oral LNC Docetaxel Results
Matinas BioPharma Holdings, a clinical-stage biopharmaceutical company specializing in revolutionary therapies utilizing its lipid nanocrystal (LNC) platform technology, has disclosed encouraging outcomes from an in...
Q4 Projections of Uber Hint at Strong Year-End Finish, Stocks Decline
Ride-hailing and food delivery company Uber Technologies (UBER) announced on Tuesday its projections of fourth-quarter (Q4) gross bookings and adjusted core profit surpassing market expectations....
Small Business Owners Grapple with Surge in Prices Amid Persistent Inflation
Small business proprietors are grappling with the relentless surge in prices of essential goods, as inflation maintains its grip on the economy. The Make Your...
Global Logistics Difficulties Hit 26-Year Low, Federal Reserve Bank of New York Reports
Global logistics difficulties have reached their lowest point in more than a quarter-century, as revealed by the Federal Reserve Bank of New York’s Global Supply...
Russell 2000 Index Marks Strongest Week in Over Two Years
In a notable surge, the Russell 2000 index (^RUT) experienced its most robust performance in more than two years, reflecting a renewed investor confidence in...
Prelude Therapeutics’ Q3 Results Ignites Bullish Rally, Stock Surges 33%
Prelude Therapeutics Inc, a clinical-stage precision oncology company, unveiled its third-quarter (Q3) financial results and strategic pipeline updates in a report released last week. The...
Positive Data Boosts Candel Therapeutics Stock as CAN-2409 Shows Promise
In a significant stride forward for the field of oncology, Candel Therapeutics, a clinical stage biopharmaceutical company, unveiled promising interim survival and immunological biomarker data...
Real Good Food Company Stock Trends Downward Ahead of Earnings Report
In its upcoming financial report, the Real Good Food Company is anticipated to announce a quarterly loss of $0.26 per share, according to the Zacks...
Tenon Medical Stock Soars Over 62% Following FDA Inspection
The stock of Tenon Medical Inc is experiencing a remarkable surge of over 62% today, following the announcement that the US Food and Drug Administration...